Sunepitron, formerly known as CP-93,393 or CP-93,393-1 (HCl), is a combined 5-HT1A receptor agonist and α2-adrenergic receptor antagonist. It was previously under development by Pfizer for the treatment of depression and anxiety. It made it to phase III clinical trials before being discontinued. References: Ahsan ZS, Song Y, Yao J. Outcomes of ulnar shortening osteotomy fixed with a dynamic compression system. J Hand Surg Am. 2013 Aug;38(8):1520-3. doi: 10.1016/j.jhsa.2013.04.040. Epub 2013 Jul 3. PubMed PMID: 23830678.

纯度：≥98%

CAS：148408-65-5